Drug manufacturers may change the list prices of their drugs at any time after launch. Over the period from January 2022 to January 2023, more than 4,200 drug products had price increases, of which 46 percent were larger than the rate of inflation. The average drug price increase over the course of the period was 15.2 percent, which translates to $590 per drug product.
Office of Health Policy (HP)
The Office of Health Policy (HP) provides a cross-cutting policy perspective that bridges Departmental programs, public and private sector activities, and the research community, in order to develop, analyze, coordinate and provide leadership on health policy issues for the Secretary. HP carries out this mission by conducting policy, economic and budget analyses, assisting in the development and review of regulations, assisting in the development and formulation of budgets and legislation, assisting in survey design efforts, as well as conducting and coordinating research, evaluation, and information dissemination on issues relating to health policy.
HP is organized in four divisions that align with major Department programs :
Division of Health Care Financing Policy (HFP)
Division of Public Health Services (PHS)
Division of Health Care Access and Coverage (HAC)
Division of Health Care Quality and Outcomes (HQO)
Health Policy Research:
- Reports to Congress
- Affordable Care Act Research & Issue Briefs
- HP Authored or Sponsored Work Published in Journals
Other Helpful Information:
Topic Areas:
- Behavioral Health
- Children's Health Insurance Program (CHIP)
- Health Equity
- Health Indicators
- Health Insurance Marketplace
- Health Policy
- Healthcare Reform
- Healthcare Safety Net
- HIV & AIDS
- Medicaid
- Medicare
- Patient-Centered Outcomes Research Trust Fund (PCORTF)
- Prevention
- Public Health
- Uninsured & Underinsured
Reports
Displaying 51 - 60 of 525. 10 per page. Page 6.
Advanced SearchReport
Trustworthy Artificial Intelligence (TAI) for Patient-Centered Outcomes Research (PCOR)
The rise of artificial intelligence (AI) in health care and health care research has stimulated discussion on the application of trustworthy principles for AI. This report summarizes 15 considerations and 14 opportunities for the implementation of HHS’s trustworthy AI principles in patient-centered outcomes research projects that incorporate AI technology.
Fact Sheet
Inflation Reduction Act Research Series: Projected Impacts for Asian, Black, and Latino Medicare Enrollees
The Inflation Reduction Act (IRA) is helping people with Medicare afford their medications, including the 2.1 million Asian, 5.8 million Black, and 5.3 million Latino Part D enrollees. These fact sheets review existing research to present the projected impacts of key IRA Medicare drug-related provisions for these populations.
Case Study, Report
Understanding the Impacts of OS-PCORTF Projects on Data Capacity: An Interim Qualitative Assessment
This report presents findings from an interim qualitative assessment that examined the ways in which OS-PCORTF projects collectively advanced the ability of researchers to conduct patient-centered outcomes research (PCOR) by (1) improving the quality of data; (2) providing more relevant, comprehensive data; (3) enhancing analytical resources; and (4) reducing barriers to data access and use.
Fact Sheet, Report
Inflation Reduction Act Research Series: Understanding Development and Trends in Utilization and Spending for Drugs Selected Under the Medicare Drug Price Negotiation Program
The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition.
Report
The Inflation Reduction Act of 2022: One Year Anniversary Highlights from ASPE Drug Pricing Reports
Introduction
Report
Assessing Outcomes Relevant for Patient-Centered Outcomes Research Among Adults Aged 18–64 with Disabilities and Federal Data Infrastructure Opportunities
This report and dataset inventory identifies individual-level measures for conducting patient-centered outcomes research (PCOR) relevant to adults with disabilities, aged 18–64 years.
Ownership of Hospitals: An Analysis of Newly-Released Federal Data & A Method for Assessing Common Owners
To enhance transparency in health care markets, in December 2022, the Centers for Medicare & Medicaid Services (CMS) publicly released comprehensive data on the ownership of all U.S. hospitals that are enrolled in Medicare. This report provides an overview of the available data, a methodology for assigning hospitals to chains, and several preliminary analyses to showcase the data.
National Uninsured Rate Reaches an All-Time Low in Early 2023
This Data Point examines new National Health Interview Survey (NHIS) data to assess recent changes in health coverage for the population. The most recent data finds that the national uninsured rate for all ages declined 1.9% from 2019 to 2022, with early 2023 data showing even greater decreases reaching an all-time low national uninsured rate of 7.7%.
Fact Sheet
State Fact Sheets: Impacts of the IRA and ACA on Lowering Health Care Costs
Expanding access to high-quality, affordable health care has been a priority of the Biden-Harris Administration.